X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (290) 290
Publication (42) 42
Book / eBook (3) 3
Book Chapter (3) 3
Newspaper Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (142) 142
oncology (117) 117
index medicus (92) 92
female (84) 84
male (74) 74
middle aged (72) 72
aged (62) 62
cancer (62) 62
adult (54) 54
chemotherapy (51) 51
head and neck cancer (51) 51
squamous-cell carcinoma (45) 45
survival (39) 39
prognosis (37) 37
article (35) 35
aged, 80 and over (32) 32
radiotherapy (32) 32
squamous cell carcinoma (32) 32
neoplasm staging (31) 31
human-papillomavirus (30) 30
antineoplastic combined chemotherapy protocols - therapeutic use (29) 29
care and treatment (29) 29
head (29) 29
surgery (29) 29
cetuximab (27) 27
head and neck neoplasms - pathology (27) 27
treatment outcome (26) 26
oropharyngeal cancer (24) 24
carcinoma (23) 23
carcinoma, squamous cell - pathology (23) 23
growth-factor receptor (22) 22
head and neck neoplasms - drug therapy (22) 22
analysis (21) 21
antineoplastic agents - therapeutic use (21) 21
carcinoma, squamous cell - drug therapy (21) 21
head and neck neoplasms - therapy (21) 21
human papillomavirus (21) 21
squamous cell carcinoma of head and neck (21) 21
retrospective studies (20) 20
risk factors (19) 19
survival analysis (19) 19
neck-cancer (18) 18
carcinoma, squamous cell - therapy (17) 17
combined modality therapy (17) 17
kaplan-meier estimate (17) 17
research (17) 17
carcinoma, squamous cell - metabolism (16) 16
head and neck neoplasms - metabolism (16) 16
patients (16) 16
tumors (16) 16
abridged index medicus (15) 15
papillomavirus infections (15) 15
radiation-therapy (15) 15
survival rate (15) 15
antibodies, monoclonal, humanized (14) 14
clinical trials (14) 14
disease-free survival (14) 14
follow-up studies (14) 14
health aspects (14) 14
hematology, oncology and palliative medicine (14) 14
metastasis (14) 14
plus cetuximab (14) 14
therapy (14) 14
antibodies, monoclonal - therapeutic use (13) 13
carcinoma, squamous cell - mortality (13) 13
head and neck neoplasms - mortality (13) 13
locally advanced head (13) 13
adenocarcinoma - drug therapy (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
carcinoma, squamous cell - virology (12) 12
head and neck neoplasms - virology (12) 12
quality-of-life (12) 12
trial (12) 12
usage (12) 12
epidermal growth factor (11) 11
epidermal growth factor receptor (11) 11
lung-cancer (11) 11
pancreatic cancer (11) 11
radiation (11) 11
antineoplastic agents - adverse effects (10) 10
chemoradiotherapy (10) 10
cisplatin (10) 10
colorectal-cancer (10) 10
disease progression (10) 10
drug administration schedule (10) 10
esophageal cancer (10) 10
head & neck cancer (10) 10
immunohistochemistry (10) 10
medicine (10) 10
metastases (10) 10
neoplasm metastasis (10) 10
paclitaxel - administration & dosage (10) 10
phase-ii trial (10) 10
proportional hazards models (10) 10
quality of life (10) 10
radiation therapy (10) 10
receptor, epidermal growth factor - antagonists & inhibitors (10) 10
risk (10) 10
adenocarcinoma (9) 9
breast-cancer (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 01/2018, Volume 124, Issue 1, pp. 14 - 17
Journal Article
Cancer, ISSN 0008-543X, 01/2018, Volume 124, Issue 1, pp. 14 - 17
Journal Article
Journal Article
by Cohen, Ezra E W and Cohen, Ezra and Soulières, Denis and Le Tourneau, Christophe and Dinis, Jose and Dinis, José and Licitra, Lisa and Ahn, Myung-Ju and Soria, Ainara and Machiels, Jean-Pascal and Mach, Nicolas and Mehra, Ranee and Burtness, Barbara Ann and Burtness, Barbara and Zhang, Pingye and Cheng, Jonathan and Swaby, Ramona F and Harrington, Kevin and Harrington, Kevin J and Acosta-Rivera, Mirelis and Adkins, Douglas R and Aghmesheh, Morteza and Airoldi, Mario and Aleknavicius, Eduardas and Al-Farhat, Yousuf and Algazi, Alain P and Almokadem, Salah and Alyasova, Anna and Bauman, Jessica R and Benasso, Marco and Berrocal, Alfonso and Bray, Victoria and Caponigro, Francesco and Castro, Ana and Cescon, Terrence P and Chan, Kelvin and Chaudhry, Arvind and Chauffert, Bruno and Csoszi, Tibor and De Boer, J.P and Delord, Jean-Pierre and Dietz, Andreas and Dupuis, Charlotte and Digue, Laurence and Erfan, Jozsef and Escobar Alvarez, Yolanda and Evans, Mererid and Fidler, Mary Jo and Forster, Martin David and Friesland, Signe and Ganti, Apar K and Geoffrois, Lionnel and Grant, Cliona and Gruenwald, Viktor and Hoffmann, Thomas and Horvai, Geza and Inciura, Arturas and Jang, Raymond and Jankowska, Petra and Jimeno, Antonio and Joseph, Mano and Juarez Ramiro, Alejandro and Karaszewska, Boguslawa and Kawecki, Andrzej and Keilholz, Ulrich and Keller, Ulrich and Kim, Sung-Bae and Kocsis, Judit and Kotecki, Nuria and Kozloff, Mark F and Lambea, Julio and Landherr, Laszlo and Lantsukhay, Yuri and Lazarev, Sergey Alexandrovich and Lee, Lip Way and Lifirenko, Igor Dmitrievich and Martincic, Danko and Matorin, Oleg Vladmirovhich and McGrath, Margaret and Misiukiewicz, Krzysztof and Morris, John C and Mufazalov, Fagim Fanisovich and Niu, Jiaxin and Pamoorthy Srinivasan, Devraj and Perez Segura, Pedro and Rauch, Daniel and Ribeiro, Maria Leonor and Rodriguez, Cristina and Rolland, Frederic and Russo, Antonio and Ruzsa, Agnes and Sanches, Frederico and Shin, Sang-Won and Shtiveland, Mikhail and Soulieres, Denis and Specenier, Pol and Szekanecz, Eva and Szota, Judit and van Herpen, Carla M.L and Velez-Cortes, Hector A and ... and Keynote-040 Investigators and KEYNOTE-040 investigators
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10167, pp. 156 - 167
There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour... 
CRITERIA | TRIAL | MEDICINE, GENERAL & INTERNAL | NIVOLUMAB | CANCER | CHEMOTHERAPY | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Docetaxel - adverse effects | Humans | Middle Aged | Squamous Cell Carcinoma of Head and Neck - pathology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Cetuximab - therapeutic use | Cetuximab - adverse effects | Docetaxel - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Squamous Cell Carcinoma of Head and Neck - drug therapy | Female | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Disease Progression | Head and Neck Neoplasms - pathology | Methotrexate - adverse effects | Squamous Cell Carcinoma of Head and Neck - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cetuximab - administration & dosage | Methotrexate - administration & dosage | Aged | Methotrexate | Squamous cell carcinoma | Metastasis | Therapy | Toxicity | Perforation | Clinical trials | Oncology | Cancer therapies | Metastases | Skin cancer | Anticancer properties | Pembrolizumab | Randomization | Motivation | Platinum | Neck | Safety | Medical treatment | Fatigue | Hypothyroidism | Survival | Patients | Chemotherapy | Interactive systems | Large intestine | Head and neck cancer | Ligands | Tumors
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 717 - 726
Journal Article
2014, Dietrich Bonhoeffer works, ISBN 1451469330, Volume 17, xiii, 622 pages.
Book
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 05/2014, Volume 12, Issue 5, pp. 793 - 796
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. e302 - e309
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2005, Volume 23, Issue 34, pp. 8646 - 8654
Journal Article
Cancer, ISSN 0008-543X, 05/2017, Volume 123, Issue 10, pp. 1778 - 1790
BACKGROUND The incidence of human papillomavirus (HPV)‐associated (HPV‐positive) head and neck squamous cell carcinoma (HNSCC) of the oropharynx has... 
human papillomavirus (HPV) | tumor necrosis factor receptor‐associated factor 3 (TRAF3) | prognosis | nuclear factor κB (NF‐κB) | head and neck squamous cell carcinoma | nuclear factor κB (NF-κB) | tumor necrosis factor receptor-associated factor 3 (TRAF3) | nuclear factor B (NF-B) | MULTIPLE-MYELOMA | IMMUNE-RESPONSE | VIRAL INTEGRATION | CERVICAL-CANCER | ANTIVIRAL RESPONSE | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | OROPHARYNGEAL CANCER | DNA-REPAIR | NF-KAPPA-B | INNATE IMMUNITY | Oropharyngeal Neoplasms - genetics | Papillomavirus Infections - complications | Head and Neck Neoplasms - virology | Prognosis | Deubiquitinating Enzyme CYLD | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - virology | Humans | NF-kappa B - metabolism | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - metabolism | Oropharyngeal Neoplasms - complications | Papillomavirus Infections - genetics | Squamous Cell Carcinoma of Head and Neck | Papillomavirus Infections - metabolism | TNF Receptor-Associated Factor 3 - genetics | Carcinoma, Squamous Cell - complications | Tumor Suppressor Proteins - genetics | Oropharyngeal Neoplasms - metabolism | Head and Neck Neoplasms - complications | Head and Neck Neoplasms - genetics | Papillomaviridae | Databases, Factual | Complications and side effects | Chemotherapy | Usage | Head and neck cancer | Diagnosis | Radiotherapy | Papillomavirus infections | Health aspects | Risk factors | Smoking | Cancer | Epidemics | Correlation | Genes | Radiation | Medical services | Clinical trials | Genomes | Activation | Cancer therapies | Carcinogenesis | Defects | Incidence | Metastases | Carcinogens | Human papillomavirus | Etiology | Transcription activation | Tumorigenesis | Medical research | Integration | Head | Squamous cell carcinoma | Data processing | Oropharynx | Radiation therapy | Patients | Survival | Morbidity | Radiation dosage | Side effects | Tobacco | Lysine | Medical prognosis | Biomarkers | Head & neck cancer | Mutation | Cervical cancer | Tumors | Index Medicus | Abridged Index Medicus | Original
Journal Article
JNCCN Journal of the National Comprehensive Cancer Network, ISSN 1540-1405, 11/2014, Volume 12, Issue 11, pp. 1651 - 1652
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 11, pp. 1405 - 1414
Journal Article